Last 26.00 GBp
Change Today -0.50 / -1.89%
Volume 18.2K
SPHR On Other Exchanges
As of 11:35 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

sphere medical holding plc (SPHR) Snapshot

26.50 GBp
Previous Close
26.50 GBp
Day High
26.50 GBp
Day Low
26.00 GBp
52 Week High
06/10/14 - 30.00 GBp
52 Week Low
11/25/13 - 22.25 GBp
Market Cap
Average Volume 10 Days
-0.07 GBp
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sphere medical holding plc (SPHR) Related Businessweek News

No Related Businessweek News Found

sphere medical holding plc (SPHR) Details

Sphere Medical Holding plc, together with its subsidiary, Sphere Medical Limited, researches, develops, and manufactures a range of monitoring and diagnostic products in the United Kingdom and internationally. Its products deliver real time analysis of blood gases, electrolytes, and drug levels at the patient’s bedside. The company’s products comprise Proxima system, a disposable multi-parameter microanalyser, for use in the intensive care unit and operating room; Pelorus, a propofol measurement system that measures the concentration of the intravenous anesthetic propofol in blood samples; and cardiopulmonary bypass monitor, which is used to frequently measure the blood chemistry during cardiopulmonary bypass surgery. It has a collaboration agreement with Ortho-Clinical Diagnostics, Inc. for the development of Proxima. The company was formerly known as Sphere Medical Holding Limited and changed its name to Sphere Medical Holding plc in November 2006. The company was incorporated in 2001 and is headquartered in Cambridge, the United Kingdom.

67 Employees
Last Reported Date: 03/4/14
Founded in 2001

sphere medical holding plc (SPHR) Top Compensated Officers

Chief Financial Officer, Company Secretary an...
Total Annual Compensation: 150.0K GBP
Compensation as of Fiscal Year 2013.

sphere medical holding plc (SPHR) Key Developments

Sphere Medical Holding Announces Positive Outcome for Proxima in Post Market Clinical Follow-Up Study

Sphere Medical Holding PLC announced a successful Proxima 3 Post Market Clinical Follow-up Study at the Queen Elizabeth Hospital, Birmingham, UK. The study, which was completed on schedule, met the primary end point to demonstrate excellent agreement with the standard bench top blood gas analysers at the Queen Elizabeth Hospital measuring various arterial blood parameters in a clinical setting. A total of twenty intensive care unit patients with a range of clinical conditions, including trauma, head injury, post-surgical recovery and sepsis, were included in the study. Patients were connected to the Proxima system for up to three days during which as many as thirty three blood gas measurements were obtained per Proxima device. Use of the Proxima system was carried out by the clinical staff at the Queen Elizabeth Hospital who each underwent an initial ninety minute training programme.

Sphere Medical Holding PLC Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

Sphere Medical Holding PLC announced unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, revenue was £8,000, operating loss was £3,049,000, loss before taxation was £3,003,000 and loss and total comprehensive income for the period attributable to the equity holders of the parent was £3,003,000 or 5.0 pence per basic and diluted share against revenue of £31,000, operating loss was £2,913,000, loss before taxation was £2,857,000 and loss and total comprehensive income for the period attributable to the equity holders of the parent was £2,857,000 or 7.8 pence per basic and diluted share a year ago. Cash used in operating activities was £2,986,000 against £2,683,000 a year ago. Purchase of property, plant and equipment was £9,000 against £81,000 a year ago.

Sphere Medical Holding PLC to Report First Half, 2014 Results on Sep 15, 2014

Sphere Medical Holding PLC announced that they will report first half, 2014 results on Sep 15, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPHR:LN 26.00 GBp -0.50

SPHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SPHR.
View Industry Companies

Industry Analysis


Industry Average

Valuation SPHR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 829.4x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 827.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SPHERE MEDICAL HOLDING PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at